Daniel S. Glaser - 16 Jun 2026 Form 4 Insider Report for METLIFE INC (MET)

Reporting relationship: Director
Issuer ticker: MET
Reported as of: 16 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Jun 2026, 16:11:50 UTC
Prior SEC filing: 11 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Taylor McInerney Jansen, Attorney-in-fact

Key filing fact

Daniel S. Glaser filed Form 4 for METLIFE INC (MET) on 18 Jun 2026.

Key facts

This page summarizes Daniel S. Glaser's Form 4 filing for METLIFE INC (MET).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Jun 2026, 16:11.

Change

Previous filing in this sequence was filed on 11 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001420864 Primary reporting owner

Glaser Daniel S

Relationship: Director
Address: METLIFE, INC., 200 PARK AVENUE, NEW YORK
Signature: /s/ Taylor McInerney Jansen, Attorney-in-fact
Signature date: 18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MET transaction

Common Stock

Award

Transaction value
Shares: +587
Change %: +28%
Price: $87.40^*
Shares after: 2,695
Date: 16 Jun 2026
Ownership: Direct
Footnotes: F1

MET holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 198
Date: 16 Jun 2026
Ownership: By GRAT
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Footnote F2

These shares are held in a GRAT.